-transparent.png){kind=logo}
To examine the association between methane (CH4) excretion and experimental colonic carcinogenesis, we measured CH4 excretion in rats treated with the colonic carcinogen azoxymethane (AOM, 7 mg/kg weekly for 10 weeks) and paired controls. CH4 excretion was not initially detected in either experimental or control groups, but all animals acquired positive CH4 excretion status by time of sacrifice (week 26). There was no difference between groups or among AOM-treated animals with and without tumors in the median time to onset of detectable CH4 excretion or in the amount of CH4 excreted. Our results fail to provide support for a link between CH4 excretion and experimental colonic dysplasia or adenocarcinoma.
J A Flick, and
S R Hamilton, and
F J Rosales, and
J A Perman
September 2006,
Revista espanola de enfermedades digestivas,
J A Flick, and
S R Hamilton, and
F J Rosales, and
J A Perman
August 2007,
Revista espanola de enfermedades digestivas,
J A Flick, and
S R Hamilton, and
F J Rosales, and
J A Perman
July 1990,
The British journal of surgery,
J A Flick, and
S R Hamilton, and
F J Rosales, and
J A Perman
September 1992,
Diseases of the colon and rectum,
J A Flick, and
S R Hamilton, and
F J Rosales, and
J A Perman
July 1987,
Gut,
J A Flick, and
S R Hamilton, and
F J Rosales, and
J A Perman
July 2008,
BMC cancer,
J A Flick, and
S R Hamilton, and
F J Rosales, and
J A Perman
January 1996,
Anticancer research,
J A Flick, and
S R Hamilton, and
F J Rosales, and
J A Perman
June 2015,
The American journal of gastroenterology,
J A Flick, and
S R Hamilton, and
F J Rosales, and
J A Perman
December 1988,
Annales de gastroenterologie et d'hepatologie,
J A Flick, and
S R Hamilton, and
F J Rosales, and
J A Perman
October 2004,
Revista espanola de enfermedades digestivas,
